Return On Equity of Xenon Pharmaceuticals Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xenon Pharmaceuticals Inc. quarterly and annual Return On Equity in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Xenon Pharmaceuticals Inc. Return On Equity for the quarter ending 30 Sep 2025 was -46%, a 87% decline year-over-year.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2024 was -29%, a 13% decline from 2023.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2023 was -25%, a 41% decline from 2022.
  • Xenon Pharmaceuticals Inc. annual Return On Equity for 2022 was -18%, a 24% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Xenon Pharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -46% -22% -87% 01 Jul 2025 30 Sep 2025
Q2 2025 -39% -14% -59% 01 Apr 2025 30 Jun 2025
Q1 2025 -32% -8% -33% 01 Jan 2025 31 Mar 2025
Q4 2024 -29% -3% -13% 01 Oct 2024 31 Dec 2024
Q3 2024 -25% +1% +5.1% 01 Jul 2024 30 Sep 2024
Q2 2024 -24% -1% -3.6% 01 Apr 2024 30 Jun 2024
Q1 2024 -24% -4% -22% 01 Jan 2024 31 Mar 2024
Q4 2023 -25% -7% -41% 01 Oct 2023 31 Dec 2023
Q3 2023 -26% -9% -51% 01 Jul 2023 30 Sep 2023
Q2 2023 -23% -6% -35% 01 Apr 2023 30 Jun 2023
Q1 2023 -20% +1% +3.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -18% +6% +24% 01 Oct 2022 31 Dec 2022
Q3 2022 -17% +10% +37% 01 Jul 2022 30 Sep 2022
Q2 2022 -17% +9% +35% 01 Apr 2022 30 Jun 2022
Q1 2022 -21% -3% -14% 01 Jan 2022 31 Mar 2022
Q4 2021 -24% -8% -50% 01 Oct 2021 31 Dec 2021
Q3 2021 -28% -10% -61% 01 Jul 2021 30 Sep 2021
Q2 2021 -27% -6% -30% 01 Apr 2021 30 Jun 2021
Q1 2021 -18% +16% +47% 01 Jan 2021 31 Mar 2021
Q4 2020 -16% +33% +68% 01 Oct 2020 31 Dec 2020
Q3 2020 -17% +27% +61% 01 Jul 2020 30 Sep 2020
Q2 2020 -21% +25% +55% 01 Apr 2020 30 Jun 2020
Q1 2020 -35% +13% +27% 01 Jan 2020 31 Mar 2020
Q4 2019 -49% -2% -3.6% 01 Oct 2019 31 Dec 2019
Q3 2019 -44% +16% +27% 01 Jul 2019 30 Sep 2019
Q2 2019 -45% +24% +34% 01 Apr 2019 30 Jun 2019
Q1 2019 -47% +21% +31% 01 Jan 2019 31 Mar 2019
Q4 2018 -47% +19% +28% 01 Oct 2018 31 Dec 2018
Q3 2018 -60% -7% -13% 01 Jul 2018 30 Sep 2018
Q2 2018 -69% -22% -45% 01 Apr 2018 30 Jun 2018
Q1 2018 -68% -23% -52% 01 Jan 2018 31 Mar 2018
Q4 2017 -66% -28% -74% 01 Oct 2017 31 Dec 2017
Q3 2017 -53% -19% -54% 01 Jul 2017 30 Sep 2017
Q2 2017 -48% -19% -65% 01 Apr 2017 30 Jun 2017
Q1 2017 -45% -29% -182% 01 Jan 2017 31 Mar 2017
Q4 2016 -38% -13% -51% 01 Oct 2016 31 Dec 2016
Q3 2016 -35% -19% -117% 01 Jul 2016 30 Sep 2016
Q2 2016 -29% -36% -493% 01 Apr 2016 30 Jun 2016
Q1 2016 -16% 01 Jan 2016 31 Mar 2016
Q4 2015 -25% 01 Oct 2015 31 Dec 2015
Q3 2015 -16% 01 Jul 2015 30 Sep 2015
Q2 2015 7% 01 Apr 2015 30 Jun 2015

Xenon Pharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -29% -3% -13% 01 Jan 2024 31 Dec 2024
2023 -25% -7% -41% 01 Jan 2023 31 Dec 2023
2022 -18% +6% +24% 01 Jan 2022 31 Dec 2022
2021 -24% -8% -50% 01 Jan 2021 31 Dec 2021
2020 -16% +33% +68% 01 Jan 2020 31 Dec 2020
2019 -49% -2% -3.6% 01 Jan 2019 31 Dec 2019
2018 -47% +19% +28% 01 Jan 2018 31 Dec 2018
2017 -66% -28% -74% 01 Jan 2017 31 Dec 2017
2016 -38% -13% -51% 01 Jan 2016 31 Dec 2016
2015 -25% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.